139 related articles for article (PubMed ID: 15110396)
1. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione.
Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY
Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosoglutathione and hypoxia-inducible factor-1 confer chemoresistance against carbamoylating cytotoxicity of BCNU in rat C6 glioma cells.
Yang DI; Chen SD; Yin JH; Hsu CY
Ann N Y Acad Sci; 2005 May; 1042():229-34. PubMed ID: 15965067
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
Yang JJ; Yin JH; Yang DI
Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
[TBL] [Abstract][Full Text] [Related]
5. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
6. NO-mediated chemoresistance in C6 glioma cells.
Yang DI; Yin JH; Mishra S; Mishra R; Hsu CY
Ann N Y Acad Sci; 2002 May; 962():8-17. PubMed ID: 12076959
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
8. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
[TBL] [Abstract][Full Text] [Related]
9. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
Ng WH; Wan GQ; Too HP
J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
[TBL] [Abstract][Full Text] [Related]
10. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
[TBL] [Abstract][Full Text] [Related]
11. Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
Shi Y; Hutchins W; Ogawa H; Chang CC; Pritchard KA; Zhang C; Khampang P; Lazar J; Jacob HJ; Rafiee P; Baker JE
J Mol Cell Cardiol; 2005 Apr; 38(4):625-35. PubMed ID: 15808839
[TBL] [Abstract][Full Text] [Related]
12. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
Isakovic A; Harhaji L; Dacevic M; Trajkovic V
Eur J Pharmacol; 2008 Sep; 591(1-3):106-13. PubMed ID: 18606162
[TBL] [Abstract][Full Text] [Related]
13. Nitrosoglutathione modulation of platelet activation and nitric oxide synthase expression in promotion of flap survival after ischemia/reperfusion injury.
Kuo YR; Wang FS; Jeng SF; Huang HC; Wei FC; Yang KD
J Surg Res; 2004 Jun; 119(1):92-9. PubMed ID: 15126088
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells.
Esposito E; Iacono A; Muià C; Crisafulli C; Mattace Raso G; Bramanti P; Meli R; Cuzzocrea S
J Pineal Res; 2008 Jan; 44(1):78-87. PubMed ID: 18078452
[TBL] [Abstract][Full Text] [Related]
15. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
Prasad R; Giri S; Nath N; Singh I; Singh AK
Glia; 2007 Jan; 55(1):65-77. PubMed ID: 17019693
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro.
Mazzio EA; Kolta MG; Reams RR; Soliman KF
Neurotoxicology; 2005 Jan; 26(1):49-62. PubMed ID: 15527873
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lens aldose reductase activity by nitric oxide.
Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats.
de Menezes AM; de Souza GF; Gomes AS; de Carvalho Leitão RF; Ribeiro Rde A; de Oliveira MG; de Castro Brito GA
J Periodontol; 2012 Apr; 83(4):514-21. PubMed ID: 21910597
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatocyte lipogenesis by nitric oxide donor: could nitric oxide regulate lipid synthesis?
Roediger WE; Hems R; Wiggins D; Gibbons GF
IUBMB Life; 2004 Jan; 56(1):35-40. PubMed ID: 14992378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
